Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6) (Q79426026)
Jump to navigation
Jump to search
scientific article published on 11 December 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6) |
scientific article published on 11 December 2006 |
Statements
Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6) (English)
Barbara Schmalfeldt
Uwe Wagner
Andreas du Bois
Jacobus Pfisterer
Jens Huober
Sybille Loibl
Hans-Joachim Lück
Jalid Sehouli
Martina Gropp
Anne Stähle
Werner Meier
Christian Jackisch
AGO Ovarian Cancer Study Group
11 December 2006